CorNeat Vision
A new era of medical devices
Startup B Health Tech & Life Sciences Est. 2015
Total Raised
$18.77M
B
Last Round
$2.5M
7 rounds
Investors
2
2 public
Team
5
11-50 employees
Confidence
99/100
News
13
articles
Patents
1
About
CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger. The EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants. The EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
healthcaremedical-devicesvisually-impairedeye-diseases
Funding & Events
Nov 2017
Seed $1.45M
Undisclosed Investor(s)
Nov 2017
Non-equity $15K
Xi'an international startup competition
May 2022
Non-equity $2.5M
European Commission (Lead)
May 2020
B Round $3.4M
Undisclosed Investor(s)
Dec 2018
A Round $7.2M
Undisclosed Investor(s)
Aug 2021
Undisclosed Round $4M
Guangzhou Sino-Israel Biotech Investment Fund (GIBF) (Lead)
Apr 2018
Non-equity $200K
China (Shenzhen) Innovation & Entrepreneurship International Competition
News (13)
Sep 2, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- CorNeat Vision, an innovative ophthalmic medical device company, has announced a groundbreaking clinical achievement: the restoration of...
Product StageFDA approved/pending approval
Jun 10, 2023 · nocamels.com
growth-positive
FDA Approves Israeli Non-Degradable Synthetic Eye Tissue
CustomersExpand
Aug 25, 2021 · www.calcalistech.com
growth-positive
CorNeat Vision raises $4 million from Israeli-Chinese GIBF fund
InvestmentExpand
Feb 4, 2021 · www.jpost.com
growth-positive
https://www.jpost.com/opinion/hillels-tech-corner-corneat-vision-helping-blind-people-see-again-657891
InvestmentExpand
Jan 18, 2021 · www.israel21c.org
growth-positive
Jamal can see again, thanks to new synthetic cornea
CustomersPartners
Jan 12, 2021 · www.israelhayom.com
https://www.israelhayom.com/2021/01/12/blind-man-sees-again-thanks-to-israeli-startups-artificial-cornea/
Jan 11, 2021 · www.prnewswire.com
growth-positive
CorNeat Vision's First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Center, Ending a Decade of Blindness
CustomersExpand
Jul 20, 2020 · www.israel21c.org
growth-positive
First in-human trial of synthetic cornea starts in Israel
CustomersExpand
Jul 14, 2020 · www.prnewswire.com
growth-positive
CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation
CustomersExpand
Jan 10, 2020 · www.labiotech.eu
growth-positive
This Biotech Makes Easily Implantable Artificial Cornea Transplants
InvestmentExpand
Sep 9, 2019 · www.prnewswire.com
growth-positive
CorNeat Vision Completes Pre-clinical Phase For Synthetic Cornea and Scleral Patch
CustomersPartners
May 21, 2019 · www.jpost.com
growth-positive
https://www.jpost.com/Jpost-Tech/Business-and-Innovation/Spotlight-on-Israeli-startups-Corneat-Vision-artificial-cornea-589759
Expand
Oct 8, 2017 · www.globes.co.il
growth-positive
Israeli co CorNeat Vision unveils artificial cornea
InvestmentExpand
Details
Product Stage
Released
Employees
11-50
Exact Count
20
District
Center District
Founded
2015
Registrar
515356293
Crunchbase
corneat-vision
Locations
4 HaSheizaf Street, Ra'anana, Israel
Links
Website
LinkedIn
Admin
Last Update
Mar 25, 2024
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (5)
Gilad Litvin
Co-founder, Chairman, Chief Medical Officer
Founder
Almog Aley-raz
Co-founder & CEO & VP R&D
Founder
Gil Lotan
VP Business Development
Sapir Buchris
VP Operations and Corporate Development
Mai Akunis-Hermann
Marketing And Business Development Coordinator
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2017-10-09T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)